Efficacy of olanzapine long-acting injection in patients with acutely exacerbated schizophrenia: an insight from effect size comparison with historical oral data Full Text
BMC Psychiatry,  Clinical Article

Detke HC et al. – Patients treated acutely with olanzapine long–acting injection (LAI) showed a similar pattern of improvement to that seen historically with oral olanzapine. With the exception of injection–related adverse events, the efficacy and tolerability profile of olanzapine LAI is similar to oral olanzapine.

Methods
  • Six-week results from the olanzapine LAI study (N=404) were compared with those of 3 oral studies (study 1: olanzapine vs. haloperidol vs. placebo [N=335]; study 2: olanzapine vs. haloperidol vs. low-dose olanzapine [N=431]; study 3: olanzapine vs. placebo vs. low-dose olanzapine [N=152]).
  • All patients had baseline Brief Psychiatric Rating Scale (BPRS) scores >=24 (0-6 scale).
  • Six-week effect sizes were calculated.
  • Efficacy onset, pharmacokinetics, discontinuations, weight gain, and extrapyramidal symptoms were also assessed.

Results
  • At 6 weeks, mean BPRS scores decreased by 14 to 15 points for olanzapine LAI (405 mg/4 weeks, 210 or 300 mg/2 weeks), by 8 to 16 for oral olanzapine (10+/-2.5 or 15+/-2.5 mg/day), and by 12 to 13 for haloperidol (15+/-5 mg/day).
  • For those same dose groups, effect sizes vs. placebo for the BPRS were 0.7 to 0.8 for olanzapine LAI, 0.5 to 0.7 for oral olanzapine, and 0.6 for haloperidol.
  • The first statistically significant separation from placebo on the BPRS occurred at 3 days for the olanzapine LAI groups and at 1 week for oral olanzapine and haloperidol (15+/-5 mg/day) in oral study 1 although as late as week 6 for the 10-mg/day olanzapine dose in oral study 3.
  • Olanzapine concentrations were similar across studies.
  • Weight gain >=7% of baseline occurred in up to 35% of olanzapine LAI and oral patients versus up to 12% of haloperidol and placebo patients.
  • Extrapyramidal symptoms were lowest in the olanzapine LAI groups and significantly greater in the haloperidol groups.
  • No post-injection delirium/sedation syndrome events occurred in the olanzapine LAI study.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Psychiatry

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Psychiatry Articles

1 Zolpidem and the risk of Parkinson's disease: A nationwide population-based study Journal of Psychiatric Research, August 1, 2014    Clinical Article

2 The effect of bupropion XL and escitalopram on memory and functional outcomes in adults with major depressive disorder: Results from a randomized controlled trial Psychiatry Research, August 5, 2014    Clinical Article

3 Prazosin in the treatment of PTSD Journal of Psychiatric Practice, July 25, 2014    Review Article

4 Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study Journal of Affective Disorders, July 17, 2014    Clinical Article

5 Risk of suicidal behavior with antidepressants in bipolar and unipolar disorders The Journal of Clinical Psychiatry, August 4, 2014    Clinical Article

6 Association of testosterone levels and future suicide attempts in females with bipolar disorder Journal of Affective Disorders, July 17, 2014    Clinical Article

7 The relationship between serum BDNF level and depression Full Text Neuropsychiatric Disease and Treatment, August 14, 2014    Free full text    Clinical Article

8 The effect of desvenlafaxine 50 mg/day on a subpopulation of anxious/depressed patients: a pooled analysis of seven randomized, placebo-controlled studies Human Psychopharmacology: Clinical and Experimental, August 20, 2014    Clinical Article

9 Association between early temperament and depression at 18 years Depression and Anxiety, August 18, 2014    Clinical Article

10 Levomilnacipran: A new serotonin-norepinephrine reuptake inhibitor for the treatment of major depressive disorder Annals of Pharmacotherapy, July 28, 2014    Review Article    Clinical Article

11 Mild traumatic brain injury and ADHD: A systematic review of the literature and meta-analysis Journal of Attention Disorders, August 25, 2014    Evidence Based Medicine

12 Treatment response and remission in a double-blind, randomized, head-to-head study of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit hyperactivity disorder CNS Drugs, August 11, 2014    Clinical Article

13 A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin–noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine Human Psychopharmacology: Clinical and Experimental, August 22, 2014    Clinical Article

14 Adding psychotherapy to antidepressant medication in depression and anxiety disorders: A meta-analysis FOCUS, August 26, 2014    Evidence Based Medicine    Clinical Article

15 Oral contraceptive use and psychiatric disorders in a nationally representative sample of women Archives of Women's Mental Health, August 29, 2014    Clinical Article

16 Efficacy of vilazodone on anxiety symptoms in patients with major depressive disorder International Clinical Psychopharmacology, July 3, 2014    Clinical Article

17 Associations between mood, anxiety or substance use disorders and inflammatory markers after adjustment for multiple covariates in a population-based study Journal of Psychiatric Research, August 7, 2014    Clinical Article

18 Efficacy of atomoxetine in adults with attention deficit hyperactivity disorder: An integrated analysis of the complete database of multicenter placebo-controlled trials Journal of Psychopharmacology, July 31, 2014    Clinical Article

19 The impact of second-generation antipsychotic adherence on positive and negative symptoms in recent-onset schizophrenia Schizophrenia Research, August 15, 2014    Clinical Article

20 Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety Journal of Psychiatric Research, August 21, 2014    Clinical Article

Indexed Journals in Psychiatry : Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addictionmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close